Table I.
Clinical and demographic data of stroke patients
| Patient No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Age (year) | 42 | 48 | 53 | 52 | 51 | 43 | 50 | 55 | 41 | 52 |
| Gender | M | M | M | M | M | M | M | M | M | F |
| LV (mL) | 20.1 | 17.9 | 13.3 | 11.0 | 4.4 | 3.5 | 4.2 | 2.3 | 31.1 | 4.3 |
| Lesion locations | IC | IC | IC | IC | IC | IC | IC | IC | IC | IC |
| CR | CR | CR | CR | CR | CR | CR | CR | |||
| BG | BG | BG | BG | |||||||
| Past medical history | – | HT | – | HT | HT | HT | HT | HT | DT | HT |
| HL | DT | |||||||||
| No. of scans | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 3 |
| TP1 (days) | 4 | 1 | 2 | 0 | 4 | 1 | – | 6 | 4 | 2 |
| TP2 (days) | 13 | 12 | 16 | 14 | – | 9 | 11 | 12 | 13 | 12 |
| TP3 (days) | 32 | 35 | 34 | 30 | 27 | – | 33 | 31 | 29 | – |
| TP4 (days) | 147 | 88 | 97 | 92 | 93 | 49 | 93 | 91 | 111 | 115 |
| TP5 (days) | 354 | 301 | 350 | 369 | 411 | 300 | 432 | – | 375 | – |
| MI 1 | 16.5 | 0 | 7 | 70.5 | 7 | 14 | – | 18.5 | 0 | 7 |
| MI 2 | 44 | 7 | 29 | 91.5 | – | 23.5 | 43 | 26.5 | 7 | 14 |
| MI 3 | 65 | 9.5 | 44 | 99 | 23.5 | – | 69 | 45.5 | 16.5 | – |
| MI 4 | 95 | 41 | 56.5 | 99 | 44 | 63.5 | 89.5 | 51 | 39 | 49.5 |
| MI 5 | 95 | 47.5 | 56.5 | 99 | 58 | 65 | 91.5 | – | 41.5 | – |
TP 1–5 represent the specific MR acquisition time (days after stroke) of each time point, and MI 1–5 represent the specific MI score for each patient at each time point.
BG, basal ganglia; CR, corona radiate; DT, diabetes; F, female; HL, hyperlipidemia; HT, hypertension; IC, internal capsule; LV, lesion volume; M, male; MI, Motricity Index (0–100); TP, time point.